Cornet M, Mallat H, Somme D, Guérot E, Kac G, Mainardi J L, Fornes P, Gutmann L, Lavarde V
Microbiologie, Hôpital Européen Georges Pompidou, 20-40 rue Leblanc, 75908 Paris Cedex 15, France.
Clin Microbiol Infect. 2003 Dec;9(12):1224-7. doi: 10.1111/j.1469-0691.2003.00792.x.
Two cases of invasive aspergillosis (IA) in immunocompetent patients with a fulminant fatal outcome are reported. Both patients were elderly and had a history of chronic lung disease treated with prolonged inhaled corticosteroids and a short course of systemic corticosteroids. They presented with dyspnea and fever, their respiratory function deteriorated rapidly, and they died 7 days after admission. Aspergillus fumigatus was cultured from respiratory samples. IA was confirmed in one case by necropsy that showed diffuse bilateral necrotizing pneumonitis and myocarditis. In the other case, IA diagnosis was established by thoracic CT scan plus detection of Aspergillus antigen in two blood samples. These two cases demonstrate that short-term corticosteroid therapy in immunocompetent patients with underlying chronic lung conditions is a risk factor for IA, and that its evolution can be fulminant.
报告了两例免疫功能正常患者发生的侵袭性曲霉病(IA),均导致暴发性致命结局。两名患者均为老年人,有慢性肺病病史,长期吸入皮质类固醇治疗,并短期使用过全身性皮质类固醇。他们表现为呼吸困难和发热,呼吸功能迅速恶化,入院7天后死亡。呼吸道样本培养出烟曲霉。其中一例通过尸检确诊为IA,显示双侧弥漫性坏死性肺炎和心肌炎。另一例通过胸部CT扫描及两份血样中曲霉抗原检测确诊为IA。这两例病例表明,有潜在慢性肺病的免疫功能正常患者短期使用皮质类固醇治疗是IA的一个危险因素,且其病情发展可能是暴发性的。